Curis, Inc. (CRIS) vs NEXGEL, Inc. (NXGL)
A side-by-side comparison of Curis, Inc. and NEXGEL, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRIS
Curis, Inc.
$0.76HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT
NXGL
NEXGEL, Inc.
$0.17HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT
Total return — CRIS vs NXGL
growth of $100 · dividends reinvested · last 5yCRIS -100.0% (-79.2%/yr)NXGL -95.2% (-45.5%/yr)NXGL compounded faster over this window
Log scale — wide-divergence pair
CRIS NXGL
CRIS vs NXGL: by the numbers
- •CRIS is the larger company ($1M vs $1M market cap).
- •Both run net losses; NXGL's is the smaller (-51.26% vs -490.33% net margin).
- •NXGL grew revenue faster over the past five years (63.69% vs -15.88% CAGR).
Metrics side by side
Valuation
| Metric | CRIS | NXGL |
|---|---|---|
| P/S ratio | 0.34 | 0.12 |
| P/B ratio | 0.32 | 0.29 |
Profitability
| Metric | CRIS | NXGL |
|---|---|---|
| Gross margin | 99.28% | 35.07% |
| Operating margin | -348.43% | -29.35% |
| Net margin | -490.33% | -51.26% |
| ROE | -450.54% | -124.97% |
| ROIC | -567.17% | -41.80% |
Growth (annualized)
| Metric | CRIS | NXGL |
|---|---|---|
| Revenue CAGR (5Y) | -15.88% | 63.69% |
| Total return CAGR (5Y) | -81.06% | N/A |
Frequently asked
- Which has grown faster, CRIS or NXGL?
- Over the past five years, NXGL grew revenue faster — CRIS at a -15.88% CAGR versus NXGL at 63.69%.
Go deeper
Dig into the metrics
Curis ROENEXGEL ROECuris operating marginNEXGEL operating marginCuris revenue growthNEXGEL revenue growthCuris free cash flowNEXGEL free cash flow
Curis & NEXGEL appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.